DRUG

amantadine

4 hypotheses across 2 therapeutic domains

ALL HYPOTHESES

Repurposing candidates for amantadine

ALS 2

Mediator Outcome Score Tier Lit. status Trial
NMDA receptor pain 0.269 Mid reproduces known active
NMDA receptor cell-autonomous excitotoxicity 0.269 Mid novel signal none

Epilepsy 2

Mediator Outcome Score Tier Lit. status Trial
NMDA receptor neurodevelopmental disorders 0.269 Mid partial evidence completed
NMDA receptor neuronal death 0.269 Mid partial evidence none

Clinical trials

200 registered trials for amantadine

Source: ClinicalTrials.gov